Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
West Pharmaceutical Services, Inc. - SIC # 3850 -
Ticker
Exchange
SIC #
Website
Latest Ticker
WST
New York
3850
www.westpharma.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for West Pharmaceutical Services, Inc.
Revvity to Acquire Human Cell Design to Boost Metabolic Discovery
- Sep 11th, 2026 9:19 am
IceCure Secures China NMPA Approval for ProSense Cryoablation System
- Sep 11th, 2026 7:57 am
Here's Why You Should Retain Ecolab Stock in Your Portfolio Now
- Sep 10th, 2026 10:57 am
COO Q3 Earnings Top Estimates, Revenues Miss on Destocking, Stock Down
- Sep 10th, 2026 8:45 am
3 Profitable Stocks with Warning Signs
- Sep 10th, 2026 7:05 am
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
- Sep 9th, 2026 10:06 am
GE HealthCare Moves StarGuide GX 4D SPECT/CT Toward FDA Clearance
- Sep 9th, 2026 10:04 am
The Cooper Companies Gears Up to Post Q3 Earnings: What's in Store?
- Sep 9th, 2026 6:31 am
PACS Expands Florida Footprint With 32-Facility Acquisition
- Sep 8th, 2026 9:40 am
Nyxoah Stock Down Despite First Genio Implant in U.S. BREATHE Trial
- Sep 8th, 2026 9:17 am
Philips Expands Women's Health Ultrasound Portfolio With New Transducer
- Sep 7th, 2026 10:20 am
Novocure Reports Patient Data Exposure in Cybersecurity Incident
- Sep 7th, 2026 9:12 am
Do You Believe West Pharmaceutical Services (WST) Represents a Tremendous Opportunity?
- Sep 7th, 2026 7:42 am
West Pharmaceutical Services (WST) And The GLP 1 Story Behind Its Fair Value Gap
- Sep 4th, 2026 8:13 pm
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now
- Sep 4th, 2026 1:39 pm
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
- Sep 4th, 2026 8:51 am
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC
- Sep 4th, 2026 8:45 am
Here's Why You Should Retain NeuroPace Stock in Your Portfolio for Now
- Sep 4th, 2026 7:58 am
Cencora Launches Cell and Gene Therapy Enablement for Health Systems
- Sep 4th, 2026 7:37 am
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now
- Sep 3rd, 2026 11:39 am
Scroll